… reports is usually mild and requires no additional antiviral treatment. We present the cases
of COVID-19 relapse (COVID-19 rebound) in two patients following treatment with Paxlovid. …

… drug called "Paxlovid" exhibited good effectiveness against COVID-19. Paxlovid™ is the …
Adults with COVID-19 who were symptomatic but not-hospitalized, had risk factors (at least …

… Paxlovid) are effective in reducing the mortality and hospitalization rates in patients with
COVID-19. … COVID-19 recovery and have the potential to be a breakthrough and very promising …

… treatment...or repeating a treatment course of Paxlovid in patients with recurrent COVID-19
symptoms following completion of a treatment … each 5-day course of Paxlovid. The drug is a …

… emergency use authorisation for Pfizer's COVID-19 antiviral, Paxlovid. Trial results released
by … mild-to-moderate COVID-19 and at least one risk factor for severe illness, treatment with …

… The coronavirus disease 2019 (COVID-19) antiviral nirmatrelvir/ritonavir (Paxlovid) has …
in several countries for the treatment of patients with mild to moderate COVID-19 at high risk of …

… Furthermore, Paxlovid may not be cost-effective in vaccinated populations, and concerns …
with COVID-19 comorbidity medications. We call for expanded coverage by the Paxlovid-MPP …

… equitable access to COVID-19 tests, treatments, and vaccines. The … in access to COVID-19
treatments will soon resemble, if not … for your oral antiviral treatment, Paxlovid, by significantly …

… described the hospitalization of COVID-19 patients. Our … and hospitalization among COVID-19
patients in the Paxlovid vs. … the Paxlovid treatment is effective for patients with COVID-19, …

… Our study is aimed to access the efficacy and safety outcomes for coronavirus disease
2019 (COVID-19) patients treated with Paxlovid. According to inclusion and exclusion criteria, …